000963 Share Price Performance
CN¥41.55
5.02 (13.74%)
Price CN¥41.55
Share PriceCN¥41.55
Huadong Medicine Co., Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
000963 Community Narratives
There are no narratives available yet.
Recent 000963 News & Updates
Huadong Medicine Co., Ltd Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 28, 2025
- Earnings per share (EPS)
- 2.08
- Gross Margin
- 33.77%
- Net Profit Margin
- 8.52%
- Debt/Equity Ratio
- 10.8%
Huadong Medicine Co., Ltd Competitors
Snowflake Analysis
About 000963
- Founded
- 1993
- Employees
- 18265
- CEO
- WebsiteView website
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, and medical apparatus and equipment. It also manufactures and sells antibiotics, Chinese patent medicines, synthetic drugs, and genetic engineering drugs; and engages in pharmaceutical logistics and industrial microbiology activities. In addition, the company provides business, leasing, and warehousing services. The company has a strategic cooperation agreement with SynerK PharmaTech (Suzhou) Co., Ltd. to develop the small nucleic acid (siRNA) drug SNK-2726, an angiotensinogen (AGT) for the treatment of hypertension. Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.3%
- 1 Year: 24.1%
- Year to Date: 26.2%
The Industrials sector has led the market, which has gained 1.8%. The market is up 24% over the last 12 months. Looking forward, earnings are forecast to grow by 27% annually. Market details ›